45.18MMarket Cap-80.17P/E (TTM)
5.320High4.746Low41.48KVolume4.925Open4.750Pre Close206.71KTurnover1.33%Turnover RatioLossP/E (Static)9.39MShares22.82552wk High-3.28P/B14.96MFloat Cap3.81052wk Low--Dividend TTM3.11MShs Float209.262Historical High--Div YieldTTM12.09%Amplitude3.810Historical Low4.982Avg Price1Lot Size
Serina Therapeutics Stock Forum
...
📊⚡️📊
3 MINUTES AGO, 6:00 AM EST
VIA GLOBENEWSWIRE
Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Serina Therapeutics (NYSE: SER) has announced a upcoming webinar presentation focused on continuous drug delivery solutions for Parkinson's disease. The event, titled 'Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond,' will feature CEO Steven A. Ledger and is scheduled for December...
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...
NFA = not financial advice
RTH = regular trading hours
AH = after hours
LTB = left to borrow
CTB = cost to borrow
*I removed $AmpliTech Group (AMPG.US)$ because it just announced direct offering of $2M valued $1.6/shares. Now there are offerings where market defies it and continues to rally. We shall see tomorrow
$Nuburu (BURU.US)$ PR AH 12/11: Resolved compliance issue. Up AH. Low float. CTB...
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
Wednesday, 11th December at 6:05 am
HUNTSVILLE, AL, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ("Serina") (NYSE: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug delivery technology, announced that Serina Therapeutics' Chief Development Officer, Randall Moreadith, MD, PhD, will be presenting today at the 3rd Annual LNP...
$Chimerix (CMRX.US)$ PR 12/9 after hours To Submit Dordaviprone For Accelerated Approval To U.S. FDA For Patients With Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End. Ran 100%+ but this is after hour news with conference call tomorrow at 8:30AM ET. May co...
SEC· 4 mins ago
📊⚡️📊
No comment yet